Actemra & Systemic Juvenile Idiopathic Arthritis « Rheumatoid Arthritis Guy

Links shared publicly online about this topic.

  • 1,075
    total visits

Actemra & Systemic Juvenile Idiopathic Arthritis « Rheumatoid Arthritis Guy

rheumatoidarthritisguy.com

Actemra & Systemic Juvenile Idiopathic Arthritis « Rheumatoid Arthritis Guy

View full resource at rheumatoidarthritisguy.com

Tags: Arthritis, Rheumatoid Arthritis, Rheumatoid Arthritis Medication, Juvenile Rheumatoid Arthritis, Children's Health, Actemra

  • Share

Most Recently Shared on June 22, 2010 at 3:58 pm By:

RA_Guy RA Guy

Actemra & Systemic Juvenile Idiopathic Arthritis http://bit.ly/bCBnhI

2 years ago...

Roche claims arthritis drug tops rival in trials - NEWS - General articles - Pharmaceutical Industry - PMLiVE

pmlive.com — “Pharmaceutical Industry | NEWS | General | Roche claims arthritis drug tops rival in trials - RoActemra reduces RA symptoms more effectively than Humira in phase IV trial | PMLiVEView full resource at pmlive.com

  • View Related
  • Share

Most Recently Shared on March 5, 2012 at 10:59 am By:

DerekDowell Derek Dowell Patient Expert

Roche claims arthritis drug tops rival in trials http://t.co/pUeo5qUF

2 months ago...

Preliminary results from Genentech's ACTEMRA monotherapy study on RA

news-medical.net — “Genentech, a member of the Roche Group, today announced that preliminary results from the ADACTA (ADalimumab ACTemrA) study showed that patients who received ACTEMRA (tocilizumab) as monotherapy achieved a significantly greater reduction in disease activity after 24 weeks than those given adalimumab monotherapy.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on March 2, 2012 at 6:13 pm By:

Arthritis_News News-Medical.Net Health News

Arthritis News: Preliminary results from Genentech's ACTEMRA monotherapy study on RA: Genentech, a member of the... http://t.co/J7dLGPXx

2 months ago...

Jab that ends the agony of childhood arthritis: New NHS treatment brings relief to nine in ten young patients | Mail Online

dailymail.co.uk — “NICE has approved RoActemra (tocilizumab) to treat systemic juvenile idiopathic arthritis (sJIA) which is currently incurable.View full resource at dailymail.co.uk

  • View Related
  • Share

Most Recently Shared on February 4, 2012 at 11:25 pm By:

DerekDowell Derek Dowell Patient Expert

Jab that ends the agony of childhood arthritis: New NHS treatment brings ... http://t.co/UNyqvFt2

3 months ago...

ACTEMRA (tocilizumab) | Rheumatoid Arthritis Treatment

actemra.com — “Find information about ACTEMRA, an FDA-approved treatment for rheumatoid arthritis. ACTEMRA is a prescription medicine called an interleukin-6 (IL-6) receptor inhibitor. ACTEMRA is used to treat adults with moderately to severely active rheumatoid arthritis (RA) after at least one other medicine called a Tumor Necrosis Factor (TNF) antagonist has been used and did not work well. ACTEMRA is used to treat people with active systemic juvenile idiopathic arthritis (SJIA) 2 years of age and older. SoView full resource at actemra.com

  • View Related
  • Share

Most Recently Shared on January 20, 2012 at 3:35 pm By:

RxEconsult, LLC - Actemra for rheumatoid arthritis and systemic juvenile idiopathic arthritis

rxeconsult.com — “RxEconsult, LLC - Actemra for rheumatoid arthritis and systemic juvenile idiopathic arthritisView full resource at rxeconsult.com

  • View Related
  • Share

Most Recently Shared on October 18, 2011 at 3:02 am By:

RxEconsultRxEconsult. If you are in need of healthcare services or information, please visit RxEconsult. 

Dr. Ogbru received his Doctorate in Pharmacy from the University of the Pacific School of Pharmacy in 1995. He completed a Pharmacy Practice Residency at the University of Arizona/University Medical Center in 1996. He was a Professor of Pharmacy Practice and a Regional Clerkship Coordinator for the University of the Pacific School of Pharmacy from 1996-99.

Dr. Ogbru has written several journal articles. In 1997, he shared an award from the American Journal of Pain Management for Outstanding Contribution to the Interdisciplinary Pain Management Literature. Over the last 12 years Dr. Ogbru has held several roles in the pharmaceutical industry, including Director of Global Medical Information and Communication." /> Ome Ogbru, PharmD Active Health Library, Doctor, Pharmacist, and PharmD

#Actemra for rheumatoid #arthritis and systemic juvenile idiopathic arthritis http://t.co/zPw6uiBI #Medications #healthcare

6 months ago...

Mutant genes found for asthma, point to possible therapy | Reuters

reuters.com — “HONG KONG (Reuters) - A drug used to treat rheumatoid arthritis could help asthma patients, scientists said on Friday, as they identified two mutant genes that may predispose a person to asthma.OverView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on September 9, 2011 at 12:25 pm By:

wheezemd Michael Blaiss, MD Doctor, Allergist, and Physician

Mutant genes found for asthma, point to possible therapy | Reuters - http://t.co/GsxeIf9

7 months ago...

Mutant genes found for asthma, point to possible therapy | Reuters

reuters.com — “* Asthma may be linked to two mutant genes * Experts see use in rheumatoid arthritis drug for asthma By Tan Ee Lyn HONG KONG, Sept 9 (Reuters) - A drug used to treatrheumatoid arthritis couldView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on September 9, 2011 at 6:16 am By:

reutersBenHir Ben Hirschler Health Communicator

Mutant genes discovery suggests Roche's Actemra may help in asthma ... http://t.co/tHYEZes

7 months ago...

A Study of RoActemra/Actemra (Tocilizumab) in Patients With Ankylosing Spondylitis Who Have Failed Treatment With NSAIDs - Full Text View - ClinicalTrials.gov

clinicaltrials.gov — “A Study of RoActemra/Actemra (Tocilizumab) in Patients With Ankylosing Spondylitis Who Have Failed Treatment With NSAIDs - Full Text View - ClinicalTrials.govView full resource at clinicaltrials.gov

  • View Related
  • Share

Most Recently Shared on August 30, 2011 at 10:45 pm By:

Roche Trial Information:

roche-trials.com — “Roche Trial Information:View full resource at roche-trials.com

  • View Related
  • Share

Most Recently Shared on August 30, 2011 at 10:36 pm By:

spondylitis Spondylitis.org Health Organization

@_connectedcare @ArtAppleADay Yes, & looks like they're recruiting in a # of countries http://t.co/qA8sDiE > #actemra clinical trials #AS

8 months ago...

Key Account Specialist – Actemra Memphis | Walnut Creek Chiropractic

walnutcreekchiropractic.org — “Key Account Specialist – Actemra Memphis | Walnut Creek ChiropracticView full resource at walnutcreekchiropractic.org

  • View Related
  • Share

Most Recently Shared on August 12, 2011 at 1:27 am By:

Article > NICE seeks more info on RoActemra in childhood arthritis

pharmatimes.com — “Article > NICE seeks more info on RoActemra in childhood arthritisView full resource at pharmatimes.com

  • View Related
  • Share

Most Recently Shared on August 11, 2011 at 11:30 am By:

FiercePharma FiercePharma Health Site

NICE wants more info on Roche's RoActemra for systemic juvenile arthritis. Comparative data, LT follow-up, etc. http://bit.ly/rhiIfQ

8 months ago...

Key Account Specialist – Actemra Memphis | Walnut Creek Chiropractic

walnutcreekchiropractic.org — “Key Account Specialist – Actemra Memphis | Walnut Creek ChiropracticView full resource at walnutcreekchiropractic.org

  • View Related
  • Share

Most Recently Shared on July 29, 2011 at 4:54 pm By:

Is It Ethical To Use Placebo In Rheumatoid Arthritis Clinical Trials? - QualityPoint Technologies

qualitypointtech.net — “The results of this study, conducted in Germany, re-open the debate on whether it is ethical to conduct placebo-controlled studies where patients in the placebo-group are at a serious disadvantage compared to patients taking the new treatments. The study analysed current study designs, for new therapies such as abatacept (Orencia®), golimumab (Simponi®) or tocilizumab (Actemra®), and showed that patients in the placebo group experienced no change in medication, having to continue with their formView full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on May 30, 2011 at 8:45 am By:

MedicalFeed MedicalFeed Health News Feed

Is It Ethical To Use Placebo In Rheumatoid Arthritis Clinical Trials?: The results of this study, conducted in Ger... http://bit.ly/jzp1Bh

11 months ago...

NICE guidance by date

guidance.nice.org.uk — “NICE guidance by dateView full resource at guidance.nice.org.uk

  • View Related
  • Share

Most Recently Shared on April 27, 2011 at 8:36 am By:

mimsonline MIMS Online Medical Publisher

NICE recommends golimumab (Simponi) for psoriatic arthritis and romiplostim (Nplate) for TTP: http://guidance.nice.org.uk/Date

12 months ago...

FDA Approves Actemra (tocilizumab) for the Treatment of Systemic Juvenile Idiopathic Arthritis (SJIA)

drugs.com — “Actemra (tocilizumab) is used to treat Rheumatoid Arthritis and Systemic Juvenile Idiopathic Arthritis . Includes Actemra side effects, interactions and indications.View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on April 19, 2011 at 4:12 am By:

Drugs_Devices Drugs and Devices OW OW Health

FDA Approves Actemra (tocilizumab) for the Treatment of Systemic Juvenile Idiopathic Arthritis (SJIA): SOU... http://bit.ly/h7x9uE #drug

1 year ago...

Advertisement